| J2323 | Injection, natalizumab, 1 mg | 30,310 | $20 | $515.2K |
| J2350 | Injection, ocrelizumab, 1 mg | 3,900 | $30 | $128.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 100 | $70 | $7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 100 | $50 | $4.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 20 | $50 | $1.2K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 30 | $20 | $580 |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 10 | $40 | $470 |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 30 | $10 | $250 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 10 | $1 | $60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 20 | $1 | $20 |